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Purpose: We report herein major determinants and long- 
term outcomes of balloon dilatation (BD) for 27 pediatric 
patients with isolated native valvular pulmonary stenosis 
(VPS).  Materials and Methods: From May 1997 to May 
2003, 27 pediatric patients with VPS (pressure gradients ≧ 
40 mmHg) were enrolled in this retrospective study. Single- 
balloon maneuver was applied in 26 patients, and double- 
balloon maneuver in 1. After BD, the pressure gradients were 
documented simultaneously by pullback maneuver by cardiac 
catheterization and echocardiography within 24 hours, at 1- 
month, 3-month, 1-year, and 4-to-10-year follow-ups. Results: 
Before BD, the echocardiographic gradients ranged from 40 
to 101 mmHg (61 ± 19, 55), and from 40 to 144 mmHg (69 
± 32, 60) by pressure recordings. After BD, the gradients 
ranged from 12 to 70 mmHg (29 ± 13, 27) by pressure recording 
(p < 0.001), and from 11 to 64 mmHg (27 ± 12, 26) by echo-
cardiography within 24 hrs (p < 0.001). The ratios of the 
systolic pressure of the right ventricle to those of the left 
ventricle were 55 to 157% (89 ± 28, 79%) before BD, and 
30 to 79% (47 ± 13, 42%) after BD (p < 0.001). Follow-up 
(7.7 ± 5.7, 4.5 years) echocardiographic gradients ranged 
from 11 to 61 mmHg (25 ± 11, 24). Two patients did not have 
immediate success owing to infundibular spasm. Improved 
right ventricular compliance could be accounted for the 
ultimate success in these 2 patients. The ultimate successful 
rate was 100%. Conclusion:  BD can achieve excellent 
long-term outcomes in the pediatric patients with isolated 
native VPS.
Key Words: Balloon dilatation, pediatric, valvular pulmonary 
stenosis
INTRODUCTION
Balloon dilatation (BD) has emerged as the 
treatment of choice for patients with valvular 
pulmonary stenosis (VPS) since 1982.
1 We report 
herein a 10-year experience of long-term outcomes 
of BD for the pediatric patients with isolated 
native VPS in our institution, describe the major 
determinants of such interventional cardiac cathe-
terization, and recommend an adjunctive treatment 
of inhaled nitric oxide for devastating pulmonary 
hypertension following BD.
MATERIALS AND METHODS
From May 1997 to May 2003, a total of 27 
consecutive patients (12 male and 15 female and 
a g e d  2  d a y s  t o  1 5 . 7  y e a r s )  w i t h  i s o l a t e d  n a t i v e  
VPS underwent BD at a tertiary medical institu-
tion in the Central Taiwan. Patients with pulmo-
nary atresia and intact ventricular septum, supra-
valvular pulmonary stenosis and/or branch 
pulmonary artery stenosis associated with the 
Williams syndrome, supravalvular pulmonary 
stenosis status post arterial switch for the dextro- 
transposition of the great artery and Taussig-Bing 
anomaly, and VPS associated with other congenital 
heart diseases were excluded from this study. BD 
was recommended to the families as an alterna-
tive to surgery if the echocardiographic pressure 
gradient was ≧ 40 mmHg across the pulmonary 
valve. Informed consent was obtained from each Valvular Pulmonary Stenosis 417
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patient’s parent(s) before BD. Fourteen infants ≦ 
6 months old were pre-medicated with intramus-
cular injection of Meperidine HCl and Clemastine 
Fumarate. Other 13 patients > 6 months old were 
pre-medicated with intramuscular injection of 
Meperidine HCl, Clemastine Fumarate, and 
Chlorpromazine HCl. Hemodynamic data were 
obtained before BD to confirm the diagnosis and 
to rule out any additional cardiac malformations 
from the right heart and left heart catheterization 
through cannulation of the femoral vein and 
artery by the standard Seldinger technique. All 
these 27 patients were heparinized (100 units/kg) 
before BD. We did not prescribe intravenous or 
oral antibiotics for prophylaxis. After documen-
tation of obstruction (≧ 40 mmHg) at the level of 
the pulmonary valve by pullback maneuver, right 
ventriculography was performed to visualize the 
pulmonary annulus in each patient, whose diameter 
could be measured by calipers after calibration. 
We performed BD in 26 patients by single-balloon 
technique, with a diameter 20% to 40% larger than 
that of the pulmonary annulus. Due to unavail-
ability of the suitable single balloon catheter at 
that time, double-balloon technique was per-
formed in 1 patient with a summated diameter 
40% larger than the pulmonary annulus. We chose 
a superstiff wire (Medi-tech, Boston, MA, USA), 
which was anchored distally into the branch 
pulmonary artery in each of the 26 patients (21 
left; 5 right) and into the descending aorta via the 
ductus in 1 patient, to offer a taut support to "rail" 
the balloon catheter crossing the stenotic 
pulmonary valve. Once the balloon catheter was 
placed in the stenotic lesion, we inflated the 
balloon 3 times at least and maintained under the 
recommended 3 - 3.5 atmospheres for no more 
than 10 seconds under fluoroscope to find out any 
indentation (waist) caused by the stenotic valve 
disappeared. After BD, the deflated balloon 
catheter was removed, and the pressure gradient 
was obtained by pullback maneuver in each 
patient. Finally, right ventriculogram was repeated 
in each patient to check the separation of the 
pulmonary valve. The whole procedures took 
from 1.5 to 3.5 hours (mean 2.2 hours), with a 
total fluoroscopic time from 30 to 55 minutes 
(mean 35 minutes). Doppler echocardiography 
was performed within 24 hours in each patient to 
check the immediate effectiveness of BD. Follow- 
up Doppler echocardiography was performed in 
each patient at varied time interval to recheck the 
ultimate successful rate. We defined successful BD 
as having 1) echocardiographic pressure gradient
≦ 40 mmHg across the pulmonary valve, and 2) 
ratio of the systolic pressure of the right ventricle 
over that of the left ventricle ≧ 80% by pressure 
tracings after BD.
2  Ineffective BD was defined as: 
1) residual gradient ≦ 40 mmHg across the pul-
monary valve by pullback pressure recording or 
by echocardiographic examination, or 2) persis-
tence of symptoms that warranted surgery 
following BD. All 27 patients were followed up 
for 4 to 10 years (7.7 ± 5.7; median 4.5 years). We 
used the Wilcoxon Signed R a n k  T e s t  t o  a n a l y z e  
statistical significance and expressed all hemo-
dynamic data as mean ± SD and median in the 
pressure tracings of cardiac catheterization and 
echocardiography with color Doppler flow 
mapping before and after BD.
RESULTS
Chart recordings of clinical manifestations, 
plain chest films, electrocardiography, echocardio-
graphy, and hemodynamic data of the cardiac 
catheterization were all available for review in all 
these 27 patients. Their clinical profiles are sum-
marized in Table 1. All 27 patients had a typical 
systolic ejection murmur over the left upper 
sternal border. Thirteen of 27 patients were 
symptomatic before BD (48%), including 9 infants 
with shortness of breath and prolonged feeding, 
and 4 children with exercise intolerance and exer-
tional dyspnea. Fourteen patients were asympto-
matic (52%). Two-dimensional echocardiography 
showed dome-shaped pulmonary valve and post- 
stenotic dilatation of the main pulmonary artery 
in 27 patients. However, there was no patient with 
dysplastic pulmonary valve. Doppler echocardio-
graphy showed turbulent flow across the pulmo-
nary valve, with the pressure gradients ranging 
from 40 to 101 mmHg (61 ± 19, median 55 mmHg). 
At cardiac catheterization, the pressure gradients 
ranged from 40 to 144 mmHg (69 ± 32, median 60
mmHg) before BD, and ranged from 12 to 70
mmHg (29 ± 13, median 27 mHg) after BD (p < Meng-Luen Lee, et al. 418
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PG (mmHg) before BD PG (mmHg) after BD Follow-up echo (mmHg) 
at 7.7 ± 5.7; 4.5 y Echo Cath sRV/sLV Cath sRV/sLV Echo
1 2 m/5 kg/M SOB 96 104 119/106 28  43/108 26 20
2 13.6 y/47 kg/M NS 55 65  79/108 30  47/112 30 21
3 2.8 y/14 kg/M NS 46 50  64/103 28  43/110 26 25
4*1
4*2
6y / 3 0k g / M













5 15.7 y/42 kg/M ED/EI 100 130   148/94 36  56/118 33 30
6 3.7 y/15 kg/F NS 55 69  82/108 40  55/106 35 20
7 12.5 y/29 kg/M ED/EI VRD 98 101 115/129 50  66/127 46 26
8 1.1 y/8 kg/F NS 44 48 58/81 23 33/72 24 23
9 1 m/4 kg/M SOB 49 51 69/75 27 48/71 26 25
10 6 m/7 kg/F NS 64 62 76/88 19 39/88 16 13
11 2 m/4 kg/F SOB 65 60 84/91 40 64/90 24 22
12*1 14 y/73 kg/F ED/EI 82 133 152/111 50  69/120 50 35
12*2 15.7 y/92 kg/F 55 50  74/112 36  60/120 36
13 1.6 y/13 kg/M NS 43 41 51/75 20 30/80 19 22
14 15.7 y/57 kg/F NS 55 61  71/106 31  41/120 33 34
15 2.9 y/11 kg/F NS 41 44 62/94 13  31/104 11 12
16 1.5 m/3 kg/F NS 50 50 74/98 25  49/100 27 18
17 3 m/5 kg/F NS 44 44 58/99 23  38/102 29 25
18 1 m/4 kg/M SOB 75 86 97/99 18 40/97 19 15
19 1.5 m/4 kg/F SOB 62 70 84/80 36 50/82 28 23
20 2 d/3 kg/M SOB 56 55 75/69 13 47/66 15 14
21 7.5 m/7 kg/F NS 43 44  58/106 24  39/103 27 27
22 3.5 m/5 kg/M SOB 52 54 73/92 21  40/116 20 11
23 2.3 m/4 kg/M NS 44 40  65/100 30  34/100 30 27
24 2.5 m/5 kg/F SOB 71 119   132/85 20 34/95 16 15
25 6.5 m/10 kg/F NS 40 40 65/83 16 31/90 14 12
26 4 m/5 kg/F SOB 54 60 78/97 36 42/88 24 22
27 5 m/7 kg/F NS 48 40 58/84 12 29/88 15 13
BD, balloon dilatation; Cath, catheter pullback pressure recording; Echo, echocardiography with color Doppler flow mapping; ED, 
exertional dyspnea; EI, exercise intolerance; NS, no specific symptoms and signs other than heart murmur; PG, pressure gradient 
across the pulmonary valve; SOB, shortness of breath; VRD, von Recklinghausen disease; M, male; F, female.
Patient 4 (*1, *2) and patient 12 (*1, *2) underwent gradational BD owing to infundibular spasm in each of them at the first try 
of BD.
0.001). The ratio of the systolic pressure of the 
right ventricle to that of the left ventricle ranged 
from 55 to 157% (89 ± 28, median 79%) before BD, 
and ranged from 30 to 79% (47 ± 13, median 42%) 
after BD (p < 0.001). Within 24 hrs after BD, the 
Doppler echocardiography showed significant drop 
of the pressure gradients, which ranged from 11 
to 64 mmHg (27 ± 12, median 26 mmHg) (p<0 . 0 0 1 ) . 
The echocardiographic gradients were lower (11 - 
61, 25 ± 11, median 24 mmHg) at the 3-month 
follow-up than those detected within 24 hrs (11 - 
64, 27 ± 12, median 26 mmHg) after BD (p = 0.03). Valvular Pulmonary Stenosis 419
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The echocardiographic gradients in the long-term 
follow-ups, at an interval of 7.7 ± 5.7 years (median 
4.5 years), were lower (22 ± 7, median 22 mmHg) 
than those documented within 24 hrs (27 ± 12, 
median 26 mmHg) after BD.
The single oversized balloon technique worked 
well when the pulmonary annulus was less than 
20 mm in diameter, and the double-balloon 
technique was necessary to provide adequate 
relief of obstruction in individuals with a pulmo-
nary annulus diameter greater than 20 mm.
3 
Double-balloon technique was used in the patient 
7, in whom the pressure gradient across the 
pulmonary valve was 50 mmHg, obtained by pull-
back pressure recording. The pressure gradients 
were 46 mmHg within 24 hrs, and 27 mmHg at 
the 1-month follow-up, measured by Doppler 
echocardiography. The patient 20 suffered from 
cyanosis 6 days after BD, due to a combination of 
ductal closure, poor compliance of the right 
ventricle with severe tricuspid regurgitation, and 
interatrial right-to-left shunting via incompetent 
patent foramen ovale, which were documented by 
Doppler echocardiography and a bubble contrast 
test. A medical emergency mimicking persistent 
pulmonary hypertension of newborn intervened 
and regressed gradually in 10 days after inhala-
tion of nitric oxide. The patient 26 had mild VPS 
(13 mmHg) when she was born prematurely (at 
the 31st gestational age). The pressure gradient 
stepped up to 54 mmHg 4 months later. Post-
prandial shortness of breath, which was found at 
the time of diagnosis, regressed after BD. Nine 
(56%) out of sixteen infants had shortness of 
breath and prolonged feeding, and 2 (50%) out of 
4 children with exertional dyspnea were free of 
symptoms after BD. The patients 4 and 12 each 
underwent a second procedure due to infundi-
bular spasm at the first try of BD. The pressure 
gradients dropped from 70 to 40 mmHg in the 
patient 4, and from 50 to 36 mmHg in the patient 
12 after a second try of BD plus administration of 
propranolol. They were asymptomatic in the 
follow-up of 6.4 years and 5 year after the second 
procedure, respectively. The immediate successful 
rate of BD was 25 out of 27 patients (93%). The 
patients 4 and 12 did not achieve immediate 
success due to severe infundibular spasm after 
BD. Improved right ventricular compliance could 
be accounted for the ultimate success of the 
repeated BD in these 2 patients, with the aid of 
propranolol. In the long-term follow-ups of 4 to 
10 years, the ultimate successful rate reached 
100% in these 27 pediatric patients. In addition, 
there was no significant pulmonary and/or 
tricuspid regurgitation causing dilatation of the 
right ventricle and the right atrium, and engor-
gement of the superior vena cava and the inferior 
vena cava in the long-term follow-ups, evidenced 
by Doppler echocardiography.
DISCUSSION
To effectively perform BD for the VPS, we first 
recommend accurate measurement of the 
pulmonary annulus, by caliper calibration on the 
lateral projection of the right ventriculogram, to 
which a suitable balloon catheter can accordingly 
be selected. From our experience, we fully agree 
with the notion that a balloon catheter with its 
balloon diameter 20% to 40% larger than that of 
the pulmonary annulus is the best choice for BD 
in patients with isolated valvular pulmonary 
stenosis.
4 However, the large-profile balloon 
catheters of 4.0 cm in length or longer, which could 
cause trauma to the pulmonary artery or tricuspid 
valve, infundibular spasm, and arrhythmia in the 
neonates,
5 infants, and small young children at 
performing BD, should not be used. The low- 
profile balloon catheters o f  n o  m o r e  t h a n  2 . 0c m  
in length are highly recommended for BD in 
neonates and infants with severe to critical 
valvular pulmonary stenosis.
6 Another advantage 
of low-profile balloon catheter is that it could be 
"railed" to cross the stenotic pulmonary valve on 
a superstiff wire anchored in the left pulmonary 
artery or in the descending aorta,
6 Thus, how to 
overcome the difficulty in manipulating a superstiff 
wire into the branch pulmonary artery or the 
descending aorta is important in attempting BD.
It is not difficult to rail a balloon catheter to 
cross the stenotic pulmonary valve and the ductus 
along a guidewire into the descending aorta by 
the maneuver of transductal guidewire "rail".
7 
However, experience has taught us that manipula-
tion of guidewire or balloon catheter in the ductus 
can result in severe ductal constriction or even Meng-Luen Lee, et al. 420
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closure that may be refractory to high doses of 
prostaglandins.
2 We did encounter a neonate, after 
radiofrequency valvulotomy and balloon valvulo-
plasty for pulmonary atresia and intact ventricular 
septum,
8 presenting intractable cyanosis due to a 
constellation of ductal constriction, poor compliance 
of the right ventricle, and interatrial right-to-left 
shunt via the incompetent patent foramen ovale, 
pathogenesis of which was very similar to that 
occurred in the patient 20, to whom nitric oxide 
was inhaled to relieve post-procedure cyanosis. 
Inhalation of nitric oxide could be used as an 
adjunctive treatment in some patients who present 
a medical emergency mimicking persistent pulmo-
nary hypertension of newborn after BD.
8 Thus, it 
is better to leave the patent ductus arteriosus 
alone in neonates with critical stenosis of the 
pulmonary valve, unless congestive heart failure 
intervenes due to increased pulmonary blood 
flow. Nevertheless, successful transaortic balloon 
valvuloplasty for the critical pulmonary stenosis 
via the patent ductus arteriosus have been 
reported by Wang et al.,
6 and Coe et al.
9
The effectiveness of BD for critical valvular 
pulmonary stenosis ranged from 43% to 94%.
6 BD 
can be the definitive therapy for critical pulmo-
nary stenosis or pulmonary atresia with intact 
ventricle septum in infants, with tricuspid valve 
annulus > 11 mm, right ventricular volume > 30 
mL/m
2, or pulmonary valve annulus ≧ 7m m .
10 
There was no instance of dysplasia or severe 
hypoplasia of tricuspid valve, pulmonary valve, 
and right ventricle in our study. This may be the 
reason of why we could achieve a successful rate 
of 100% in these 27 patients. We encountered 2 
neonates with ductus-dependent pulmonary atresia 
and intact ventricular septum, and radiofrequency 
valvulotomy and gradational balloon dilatations 
were performed. One of them, with Z value of 
tricuspid valve < - 3 and > - 4, required surgical 
shunts and inhaled nitric oxide to wean off 
prostaglandin infusion and ventilator support.
8 It 
is the anatomic morphology of the tricuspid valve, 
the right ventricle, and the pulmonary valve to 
account for the different outcomes of critical VPS 
which underwent BD at different institutions.
6,10,11 
Gradational BD was unnecessary in the present 
study, because of the absence of dysplasia of the 
tricuspid valve, the right ventricle, and the 
pulmonary valve, which are frequently seen in 
cases of pulmonary atresia with intact ventricular 
septum.
With improvement of transcatheter technique 
and equipments, either a single balloon catheter of 
low profile (better with a balloon diameter 20% to 
40% greater than that of the pulmonary annulus), 
6,11-13 or more balloon catheters of different sizes 
(with gradational dilatation) can be used to dilate 
the pulmonary valve.
5,6,12-16 In our patients with 
i s o l a t e d  n a t i v e  V P S ,  w e  u s e d  s i n g l e - b a l l o o n  
maneuver in 26 patients and double-balloon 
maneuver in one patient to dilate the pulmonary 
valve by at least 3 inflations.
Determinants for unsuccessful BD for severe to 
critical pulmonary stenosis in neonates and 
infants ≦ 6 months are smaller pulmonary valve 
annuli and severe tricuspid regurgitation, rather 
than the right ventricular size and right-to-left 
ventricular pressure ratio.
13 It is not farfetched to 
state that smaller pulmonary annulus demands 
more balloon catheters to gradationally dilate the 
pulmonary valve. However, a single balloon 
catheter of small profile can also be used to rail 
a superstiff wire to cross the stenotic pulmonary 
valve and to effectively perform BD at one time. 
This all-inclusive technique deserves a far wider 
range of attention and practice in cases of 
nonductus-dependent critical pulmonary stenosis.
Finally, propranolol can be used to reverse 
infundibular spasm which complicates BD.
17 This 
kind of functional infundibular stenosis may 
resolve with time by itself.
6,18 I n  t h i s  s t u d y ,  t h e  
echocardiographic gradients at the 3-month follow- 
up were lower (11 - 61, 25 ± 11, median 24 mmHg) 
than those detected within 24 hrs (11 - 64, 27 ± 12, 
median 26.0 mmHg) after BD. This implies that 
impingement on the infundibulum, causing 
undesirable spasm, may well occur in patients 
during and after BD, and most of them regress 
spontaneously.
18 Perforation of the right ventri-
cular outflow tract is a major complication com-
monly encountered in patients with critical pulmo-
nary stenosis undergoing BD,
2,11,12,19-22 which 
accounts for a mortality rate of 3% to 8%.
2,12,13,20-22
In summary, 1) accurate measurement of the 
pulmonary annulus, 2) selection of small low- 
profile balloon catheter with inflated diameter 
20% to 40% larger than that of the pulmonary Valvular Pulmonary Stenosis 421
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annulus, 3) successful anchorage of a superstiff 
wire onto the peripheral left pulmonary artery or 
onto the descending aorta as a rail for balloon 
catheter, and 4) absence of dysplasia of the 
tricuspid valve, right ventricle, and pulmonary 
valve are the four major determinants of successful 
BD for pediatric patients with isolated native VPS, 
especially in neonates and infants with critical 
VPS.
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